Iron Chelation Therapy in Myelodysplastic Syndromes: Where Do We Stand?

Expert Review of Hematology - United Kingdom
doi 10.1586/17474086.2013.814456
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Informa UK Limited

Related search

Blockchain in Academia: Where Do We Stand and Where Do We Go?

2020English

High Energy Neutrino Astronomy: Where Do We Stand, Where Do We Go?

Physics of Particles and Nuclei
High Energy PhysicsNuclear
2018English

Schistosomiasis Vaccines: Where Do We Stand?

Parasites and Vectors
ParasitologyInfectious Diseases
2016English

Where Do We Stand After Coty?

Competition Law Journal
2018English

Quantum Computers: Where Do We Stand?

Europhysics News
AstronomyPhysics
2005English

Iron Overload in Myelodysplastic Syndromes

Expert Review of Hematology
Hematology
2009English

Stem Cell Therapy for Lower Extremity Diabetic Ulcers: Where Do We Stand?

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2013English

Targeting Angiogenesis in Cancer Treatments: Where Do We Stand?

Journal of Pharmacy and Pharmaceutical Sciences
MedicinePharmacologyPharmaceutical Science
2016English

Artificial Intelligence Applications in Dermatology: Where Do We Stand?

Frontiers in Medicine
Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy